U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"The production of too many useful things results in too many useless people."

Karl Marx

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 514/253.02 - Polycyclo ring system having the additional six-membered nitrogen hetero ring as one of the cyclos


Subclass of Class 514 - Drug, bio-affecting and body treating compositions
Definition: Subject matter wherein the additional six-membered hetero
No. of patents: 99
Last issue date: 07/12/2011


1      
NumberTitleIssue Date
7977337Quinoline derivatives and their use as 5-HT6 ligands
Disclosed are quinoline compounds having affinity for the 5-HT6 receptor and having the formula: where R1, R2, R3, R4, R5, n, m, p and A are defined herein, ...
07/12/2011
7829567Imino-indeno[1,2-c] quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same
Disclosed herein are novel imino-indeno[1,2-c]quinoline derivatives of formula (I): or a pharmaceutically acceptable salt or solvate thereof, wherein each of the substituents is giv...
11/09/2010
7582635Therapeutic agents useful for treating pain
A compound of formula: wherein Ar1, A, R3, x, and m are as disclosed herein and Ar2 is a benzothiazolyl, benzooxazolyl, or benzoimidazolyl group or a pharmaceutically acceptable salt thereof...
09/01/2009
7309497Injectable pharmaceutical composition for systematic administration of pharmacologically active ingredients
The invention relates to novel pharmaceutical compositions for the systemic administration of pharmacologically active ingredients. The invention relates in particular to an injectable pharmaceutical composition comprising (a) a pharmacologically active ingredient i...
12/18/2007
7244701Diuretic peptide conjugate
Disclosed are a variety of peptide conjugates represented by the following general formula: R1-Z-X-Z′-R2 including methods of making and using such conjugates. Also provided are antibodies that specifically bind the pepti...
07/17/2007
7211417Antibiotic P175-A and semisynthetic derivatives thereof
This invention relates to a new antibiotic designated P175-A, to production of fermentation of Micromonospora echinospora NRRL 30633, to methods for recovery and concentration from the crude solutions, and to a process for purification and to semisynthetic es...
05/01/2007
7157452Substituted 4,9-dihydrocyclopenta{imn}phenanthridine-5-ones derivatives thereof and their uses
This invention relates to compounds, pharmaceutical compositions, and methods of using the disclosed compounds for inhibiting PARP. ...
01/02/2007
7144843Pest controllers
An objective of the present invention is to provide a harmful organism control agent that possesses excellent control effect against harmful organisms and can be safely used. The present invention provides a compound of formula (1) or a salt thereof. The present inv...
12/05/2006
7053127Quaternized amido cyclic amine surfactant
A quaternary surfactant comprising a cyclic diamine group, compositions comprising the quaternized amido cyclic amine surfactant, a gelled aqueous composition comprising the quaternized amido cyclic amine surfactant, use of the gelled aqueous well treatment applicat...
05/30/2006
6960580Nitrogenous heterocyclic substituted quinoline compounds
The present invention relates to nitrogen-containing heterocyclic quinoline compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also r...
11/01/2005
6936615Heteroaryl derivatives and their use as medicaments
The invention relates to novel quinoline derivatives of the formula 1, to their preparation and to their use as medicaments, in particular for treating tumors. ...
08/30/2005
6936610Heterocyclic derivatives
The invention relates to heterocyclic derivatives of formula (I) A—B—X1—T1(R2)—L1—T2(R3)—X2—Q  (I) or pharmaceutically-acceptable salts thereof, which ...
08/30/2005
6838456Condensed pyridoindole derivatives
Compounds of the general structural formula and use of the compounds and salts and solvates thereof, as therapeutic agents. ...
01/04/2005
6800636Farnesyl protein transferase inhibitors
Disclosed are compounds of the formula: wherein R8 represents a cyclic moiety to which is bound an imodazolylalkyl group; R9 represents a carbamate, urea, amide or sulfonamide group; and the remaini...
10/05/2004
6642225Diazacycloalkanedione derivatives
Compounds of formula I ##STR1## wherein R is carboxy, esterified carboxy or amidated carboxy; R1 and R3 are independently lower alkyl, (hydroxy, lower alkoxy, amino, acylamino, mono- or di-lower alkylamino or mercapto)-lower alkyl, ...
11/04/2003
6605610Aryl fused azapolycyclic compounds
Compounds of the formula ##STR1## and their pharmaceutically acceptable salts, wherein R1, R2, and R3 are as defined herein; intermediates for the synthesis of such compounds, pharmaceutical compositions containing such co...
08/12/2003
6593332Pharmaceutically active compounds
There is provided compounds of formula IA and of formula IB, ##STR1## wherein R1, R2, R3, Het1 and X have meanings given in the description, which are useful in the curative and prophylactic treatment of medical...
07/15/2003
6586439Pharmaceutically active compounds
There is provided compounds of formula IA and of formula IB, ##STR1## wherein R1, R2, R3, Het1 and X have meanings given in the description, which are useful in the curative and prophylactic treatment of medical...
07/01/2003
6545011Substituted 4,9-dihydrocyclopenta[imn]phenanthridine-5-ones, derivatives thereof and their uses
This invention relates to compounds, pharmaceutical compositions, and methods of using the disclosed compounds for inhibiting PARP....
04/08/2003
6541483Acridone-derived compounds useful as antineoplastic and antiretroviral agents
The present invention relates to several novel acridone-derived compounds of of formula (I) or (II). These compounds are potent anti-viral agents, useful in the treatment of viral diseases, such as Human Immunodeficiency Virus. In addition, these compound...
04/01/2003
6444676Use of PARP inhibitors in the treatment of glaucoma
The invention provides pharmaceutical compositions containing PARP inhibitors and methods of using these compositions to prevent, treat or ameliorate glaucomatous retinopathy and/or optic neuropathy....
09/03/2002
6410550Aryl fused azapolycyclic compounds
Compounds of the formula ##STR1## and their pharmaceutically acceptable salts, wherein R1, R2, and R3 are defined as in the specification, intermediates in the synthesis of such compounds. pharmaceutical compositions conta...
06/25/2002
6362188Farnesyl protein transferase inhibitors
Disclosed are compounds of the formula: ##STR1## wherein R.sup.8 represents a cyclic moiety to which is bound an imodazolylalkyl group; R.sup.9 represents a carbamate, urea, amide or sulfonamide group; and the remaining substituents are as defined herein....
03/26/2002
6358967Ergoline amine derivatives with blood pressure lowering effect
The invention relates to novel derivatives of ergoline of the general formula 1 ##STR1## in which R1 together with the two adjacent N atoms is the residue of a diamine and R4 together with the two adjacent carbonyl groups is the ...
03/19/2002
6300330Heterocycle derivatives which inhibit factor Xa
The invention relates to heterocyclic derivatives of the formula (I): A--B--X1 --T1 (R2)--L1 --T2 (R3)--X2 --Q or pharmaceutically acceptable salts thereof, which possess antithr...
10/09/2001
6221870Ergoline derivatives and their use as somatostatin receptor antagonists
The invention provides compounds of formula I ##STR1## wherein R1 to R6 are as defined in the description, and a process for preparing them. The compounds of formula I are useful as pharmaceuticals....
04/24/2001
620427316-substituted-4-aza-androstane 5-଱-reductase isozyme 1 inhibitors
Compounds of the Formula I ##STR1## are inhibitors of the 5଱-reductase 1 isozyme, and are useful alone, or in combination with a 5଱-reductase 2 inhibitor, for the treatment of androgenic sensitive disorders such as acne vulgaris, seborrhea, fe...
03/20/2001
6187775Acridone-derived compounds useful as antineoplastic and antiretroviral agents
The present invention relates to several novel acridone-derived compounds of of formula (I) or (II). These compounds are potent anti-viral agents, useful in the treatment of viral diseases, such as Human Immunodeficiency Virus. In addition, these compound...
02/13/2001
6156754Glycoconjugates of modified camptothecin derivatives (A-or B-ring linkage)
The present invention relates to glycoconjugates of camptothecin derivatives in which at least one carbohydrate component is linked via suitable spacers with the A or B ring of a camptothecin derivative. The invention furthermore relates to processes for ...
12/05/2000
6133280Androgen synthesis inhibitors
This invention relates to novel inhibitors of androgen synthesis that are useful in the treatment of prostate cancer and benign prostatic hypertrophy. The present invention also provides methods of synthesizing these novel compounds, pharmaceutical compos...
10/17/2000
6127368Anellated ଲ-carbolines
Compounds of formula I ##STR1## are described, as well as the process for their production and their use in pharmaceutical agents....
10/03/2000
6004962Rapid opioid detoxification
Rapid opioid detoxification procedures are provided which include sedating a patient with a rapid-acting, safely reversible intravenous anesthetic agent having a very short full recovery period. The patient is administered an opioid antagonist while sedat...
12/21/1999
58801254-spiroindoline piperidines promote release of growth hormone
The present invention is directed to certain novel compounds identified as 4-spiroindoline piperidines of the general structural formula: ##STR1## wherein R1, R1a, R2a, R3a, R3b, R4, R...
03/09/1999
5814642Tetracyclic condensed heterocyclic compounds their production, and use
A novel compound of the formula ##STR1## wherein Ar represents a tetracyclic fused heterocyclic group which may be substituted; R1 represents H or a hydrocarbon group which may be substituted; Y represents an amino acid or nitrogen-contain...
09/29/1998
5756512Treatment of non-small cell lung carcinoma
A method of treating non-small cell lung carcinoma in a human afflicted therewith which comprises administering to such human an effective amount of a compound of the water soluble camptothecin analog class....
05/26/1998
574179516-substituted-6-aza-androsten-4-ene-3-ones as 5-଱-reductase inhibitors
Compounds of the formula I ##STR1## are inhibitors of 5଱-reductase, and are useful for the treatment of hyperandrogenic disorders such as acne vulgaris, seborrhea, female hirsutism, male pattern baldness, prostatic carcinoma, prostatitis and ...
04/21/1998
5696127Steroid receptor modulator compounds and methods
Non-steroidal compounds which are high affinity, high selectivity modulators for steroid receptors are disclosed. Also disclosed are pharmaceutical compositions incorporating such compounds, methods for employing the disclosed compounds and compositions f...
12/09/1997
5693646Steroid receptor modulator compounds and methods
Non-steroidal compounds which are high affinity, high selectivity modulators for steroid receptors are disclosed. Also disclosed are pharmaceutical compositions incorporating such compounds, methods for employing the disclosed compounds and compositions f...
12/02/1997
5674872Treatment of ovarian cancer
A method of treating ovarian cancer in a human afflicted therewith which comprises administering to such human an effective amount of a compound of the water soluble camptothecin analog class....
10/07/1997
5670500Water soluble camptothecin analogs
The present invention provides water soluble camptothecin analogs of Formula I: ##STR1## which are particularly useful as antineoplastic agents; pharmaceutical compositions thereof; and a method of treating cancer in an animal in need thereof, i...
09/23/1997
1      
 
Sign InRegister
Username  
Password   
forgot password?